Interim results from two phase 1 trials demonstrate progress in the use of chimeric antigen receptor (CAR) T cell therapy for recurrent glioblastoma (GBM).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1126/scitranslmed.adp2660 | DOI Listing |
Publication Analysis
Top Keywords
car cell
8
next-generation car
4
cell therapies
4
therapies glioblastoma
4
glioblastoma interim
4
interim phase
4
phase trials
4
trials demonstrate
4
demonstrate progress
4
progress chimeric
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!